New Migraine Drug Might Be Safer for Some
And an old standby might help prevent headache from starting up, report finds. A drug under development could help patients with migraines, while an existing epilepsy drug might prevent the headaches from developing in the first place, new research suggests.
The report, published April 21 in The Lancet, examines the migraine drug telcagepant, which is not yet available, and topiramate (Topamax), an epilepsy drug sometimes used to treat migraines when they occur.
Telcagepant relieves pain in a similar way to the drugs known as triptans that are used to treat migraine....
More -->
More articles below:
Gene Mutation Ups Risk of Sudden Death in People with Epilepsy
New Sensors Stick to Organs to Monitor Health
Implant Shows Promise for Hard-to-Treat Epilepsy
Oldest Epilepsy Drug Best for Children
Simple Concussion Test Measures Reaction Time
View All Related Articles
DON'T HAVE Rx COVERAGE?Click Here to print out your FREE OPTIMIZERx Card and instantly begin savings on your next prescriptions!

| Rebif -MS LifeLines |
|
Overview:
That's why MS LifeLines offers a number of assistance programs designed to help you get started on Rebif and to help you stay on Rebif when prescribed |
|
Click here for more information
|
*Program offers and eligibility are independent of OPTIMIZERx, subject to change by the manufacturer and may require leaving the site to directly enroll into the manufacturer's program. Please review terms & conditions carefully.





